Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis.

Kosuke EbinaJun HashimotoMasafumi KashiiMakoto HiraoAkira MiyamaHiroyuki NakayaShigeyoshi TsujiKoichiro TakahiHideki TsuboiGensuke OkamuraYuki EtaniKenji TakamiHideki Yoshikawa

Published in: Modern rheumatology (2020)

These results may contribute to the selection of adequate follow-on therapy after DMAb discontinuation, although further investigations are required.

Keyphrases

bone mineral density
postmenopausal women
stem cells
body composition
bone marrow
mesenchymal stem cells
cell therapy